Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Int J Med Sci 2017; 14(2):123-127. doi:10.7150/ijms.17321 This issue Cite

Research Paper

Prediction of Gestational Diabetes Mellitus by Unconjugated Estriol Levels in Maternal Serum

Junguk Hur1, Eun-Hee Cho2, Kwang-Hyun Baek3, Kyung Ju Lee4,5✉

1. Department of Biomedical Sciences, University of North Dakota, Grand Forks, North Dakota, USA.
2. Department of Internal Medicine, Kangwon National University, Chuncheon, Republic of Korea;
3. Department of Biomedical Science, CHA University, Gyeonggi-Do, Republic of Korea;
4. Integrative Medicine Center, College of Medicine, Korea University, Seoul, Republic of Korea;
5. Department of Epidemiology and Medical informatics, Graduate School of Public Health, College of Medicine, Korea University, Seoul, Republic of Korea.

✉ Corresponding author: Kyung-Ju Lee, MD, PhD, Integrative Medicine Center, College of Medicine Korea University, Inchon-ro 73, Seongbuk-gu, Seoul, 02841, Republic of Korea. Tel: 82-2-920-6933; Fax: 82-2-920-6934; E-mail: drlkj52551ac.kr.

Citation:
Hur J, Cho EH, Baek KH, Lee KJ. Prediction of Gestational Diabetes Mellitus by Unconjugated Estriol Levels in Maternal Serum. Int J Med Sci 2017; 14(2):123-127. doi:10.7150/ijms.17321. https://www.medsci.org/v14p0123.htm
Other styles

File import instruction

Abstract

The aim of this study was to evaluate the association between maternal serum estriol levels, which are routinely measured in the first trimester of pregnancy, and adverse pregnancy outcomes including gestational diabetes. We performed a retrospective chart analysis of women who delivered between July 1, 2007, and December 31, 2009, at Kangnam CHA Medical Center in Seoul, Korea. Only patients with available estriol measurements during their pregnancies and complete follow-up data were included in the study. The effect of estriol on the incidence of adverse pregnancy outcomes was examined using multinomial logistic regression analysis with age and pre-pregnancy body mass index (BMI) as covariates. The total number of subjects was 1,553, the mean age was 32.9 ± 3.7 years, and the mean pre-pregnancy BMI was 21.2 ± 3.0 kg/m2. Unconjugated estriol > 95th percentile of the screened population or unconjugated estriol ≥ 2.0 MoM (Multiple of the Median) was significantly associated with an increased risk for developing gestational diabetes mellitus (GDM), after adjusting for age and pre-pregnancy maternal weight. High levels of unconjugated estriol in the maternal serum during the early second trimester of pregnancy are a useful predictor of GDM development.

Keywords: Estriol, pregnancy outcomes, gestational diabetes.

Citation styles

APA
Hur, J., Cho, E.H., Baek, K.H., Lee, K.J. (2017). Prediction of Gestational Diabetes Mellitus by Unconjugated Estriol Levels in Maternal Serum. International Journal of Medical Sciences, 14(2), 123-127. https://doi.org/10.7150/ijms.17321.

ACS
Hur, J.; Cho, E.H.; Baek, K.H.; Lee, K.J. Prediction of Gestational Diabetes Mellitus by Unconjugated Estriol Levels in Maternal Serum. Int. J. Med. Sci. 2017, 14 (2), 123-127. DOI: 10.7150/ijms.17321.

NLM
Hur J, Cho EH, Baek KH, Lee KJ. Prediction of Gestational Diabetes Mellitus by Unconjugated Estriol Levels in Maternal Serum. Int J Med Sci 2017; 14(2):123-127. doi:10.7150/ijms.17321. https://www.medsci.org/v14p0123.htm

CSE
Hur J, Cho EH, Baek KH, Lee KJ. 2017. Prediction of Gestational Diabetes Mellitus by Unconjugated Estriol Levels in Maternal Serum. Int J Med Sci. 14(2):123-127.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use